SCHEMBL4558157

SCHEMBL4558157

O=[N+]([O-])c1cccc(OCc2c[nH]c3ncncc23)c1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.37
NPC1 O15118 4/20 0.37
KMT2A Q03164 4/20 0.37
EGFR P00533 2/20 0.36
HTR1A P08908 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
MET P08581 1/20 0.34
RECQL P46063 1/20 0.34
LTA4H P09960 1/20 0.34
PLA2G2A P14555 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1093899 0.74 CYP2C9 (0.41) EGFRMETALDH1A1SMN1; SMN2KDM4E
SCHEMBL1093531 0.73 EGFR (0.36) KMT2AEGFRMETALDH1A1
SCHEMBL1085903 0.70 RPS6KA5 (0.40) RAB9AKMT2AEGFRMETMEN1
SCHEMBL7110475 0.69 HTR1A (0.53) RAB9ANPC1KMT2AHTR1AADRA1D
SCHEMBL26921178 0.67 ALDH1A1 (0.57) RAB9ANPC1KMT2ARECQLALDH1A1
SCHEMBL28892628 0.65 GAA (0.40) RAB9ANPC1KMT2AEGFRHTR1A
SCHEMBL30003246 0.65 GAA (0.40) RAB9ANPC1KMT2AEGFRHTR1A
SCHEMBL1797434 0.65 RPS6KA5 (0.42)
SCHEMBL20876320 0.64 NPC1 (0.54) RAB9ANPC1KMT2AHTR1AADRA1D
SCHEMBL8166660 0.64 NPC1 (0.48) RAB9ANPC1KMT2ARECQLALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009143024-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2009-11-26 WO disclosed